Should Biotech Be On The Critical List?
May 11, 2022 at 01:10 AM EDT
The risk-off market has played havoc with the biotechs where the fundamentals have not changed as much as the valuation.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.